2023 AACR The use of PBMC humanized mice to test the efficacy and safety of antibody and cell-based cancer immunotherapeutics
Read Flipbook
Conference Posters and Presentations
The Jackson Laboratory attends and hosts a number of conferences throughout the year. Below you will find a selection of posters our scientists have presented.
-
-
2023 AACR Novel preclinical model for the evaluation of cytokine release syndrome in response to CD19xCD3 bispecific antibody in humanized m
Read Flipbook
-
2023 AACR A new tumor-bearing humanized mouse model to evaluate the efficacy of bispecific T cell engager and monoclonal checkpoint antibodi
Read Flipbook
-
2023 AACR Comparisons of Rituximab and CD19xCD3 BiTE antitumor response across multiple humanized NSG strains engrafted with human hematopoi
Read Flipbook
-
2023 AACR Assessing individual variability in efficacy and toxicity of autologous and allogeneic chimeric antigen receptor T-cell immunother
Read Flipbook
-
2023 AACR Mouse models of cancer available from The Jackson Laboratory
Read Flipbook
-
2022 ASH Poster: In Vivo PBMC Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicology
Read Flipbook
-
2022 SfN Poster: 374.18 Exploring SARM1 Inhibition in Mouse Models of CMT (1)
Read Flipbook
-
2022 PEGS EU Immune System-Humanized Mouse Models to Predict Outcomes of Human-Specific Immuno-Modulatory Therapies
Read Flipbook
-
2022 PEGS EU A Translational Model for Drug-Induced Cytokine Release Syndrome-Associated Systemic Toxicity in the Humanized Mouse
Read Flipbook
-
2022 PEGS EU In vivo Evaluation of the Effects of Fc-Silencing Mutations on Antibody Half-Life Using FcRn Humanized Mouse Models
Read Flipbook
-
2022 SfN 613-Virtual Genetically Diverse Mouse Models of Alzheimer’s Disease Reveal an Association Between Glycan Metabolism and Cerebral Am
Read Flipbook
-
2022 SfN 613.20 Transcriptional Assessment of Novel Mouse Models Harboring Human Genetic Variants Associated With Late-Onset Alzheimer’s Dis
Read Flipbook
-
2022 SfN 624.13 Targeting the Immune Contributions to Neurodegeneration Via the Il1rap Signaling Axis
Read Flipbook
-
2022 SfN 374.05 Towards In Vivo Studies of C12ORF65MTRFR Deficiency in Mitochondrial Translation in Neurons
Read Flipbook
-
2022 SfN 283.08 Cerebral Organoids Reveal Genetic Differences Associated With Resilience in an In Vitro Stroke Model
Read Flipbook
-
2022 SfN 370.12 Characterization of Aging X Genetic X Environment as Precision Disease Models For Evaluation of Therapeutic Interventions Fo
Read Flipbook
-
2022 SfN 374.14 Sipa1l2, a Candidate Modifier of CMT1A from Human GWAS, Does Not Alter Neuromuscular Phenotypes in C3-PMP22 Mice When Delete
Read Flipbook
-
2022 SfN 374.01 Preclinical Studies Inhibiting GCN2 and the Integrated Stress Response in Mouse Models of CMT2D
Read Flipbook
-
2022 SfN 85.11 Methodology to Objectively Prioritize Therapeutic Hypotheses in Alzheimer’s Disease Via Target Risk Scoring and Biological Do
Read Flipbook
-
Loading More...
